Ye B - Search Results

1

Prostate carcinoma tissue proteomics for biomarker discovery.

Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH, O'Leary MP, Richie JP, Mok SC, Liu BC. Zheng Y, et al. Among authors: ye b. Cancer. 2003 Dec 15;98(12):2576-82. doi: 10.1002/cncr.11849. Cancer. 2003. PMID: 14669276 Free article.

2

Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.

Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Ye B, et al. Clin Cancer Res. 2003 Aug 1;9(8):2904-11. Clin Cancer Res. 2003. PMID: 12912935

3

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.

Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW. Ye B, et al. Clin Cancer Res. 2006 Jan 15;12(2):432-41. doi: 10.1158/1078-0432.CCR-05-0461. Clin Cancer Res. 2006. PMID: 16428483

4

New technologies for the identification of markers for early detection of ovarian cancer.

Bandera CA, Ye B, Mok SC. Bandera CA, et al. Among authors: ye b. Curr Opin Obstet Gynecol. 2003 Feb;15(1):51-5. doi: 10.1097/00001703-200302000-00008. Curr Opin Obstet Gynecol. 2003. PMID: 12544502 Review.

5

Recent technical strategies to identify diagnostic biomarkers for ovarian cancer.

Ye B, Gagnon A, Mok SC. Ye B, et al. Expert Rev Proteomics. 2007 Feb;4(1):121-31. doi: 10.1586/14789450.4.1.121. Expert Rev Proteomics. 2007. PMID: 17288520 Review.

6

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.

Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, Welch WR, Bandera CA, Mok SC. Gagnon A, et al. Among authors: ye b. Clin Cancer Res. 2008 Feb 1;14(3):764-71. doi: 10.1158/1078-0432.CCR-07-0856. Clin Cancer Res. 2008. PMID: 18245537 Free article.

7

Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.

Aponte M, Jiang W, Lakkis M, Li MJ, Edwards D, Albitar L, Vitonis A, Mok SC, Cramer DW, Ye B. Aponte M, et al. Among authors: ye b. Cancer Res. 2008 Jul 15;68(14):5839-48. doi: 10.1158/0008-5472.CAN-07-5771. Cancer Res. 2008. PMID: 18632638 Free PMC article.

8

Blood and urine markers for ovarian cancer: a comprehensive review.

Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW. Terry KL, et al. Among authors: ye b. Dis Markers. 2004;20(2):53-70. doi: 10.1155/2004/241982. Dis Markers. 2004. PMID: 15322314 Free PMC article. Review. No abstract available.

9

Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells.

Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. Batorfi J, et al. Among authors: ye b. Gynecol Oncol. 2003 Mar;88(3):424-8. doi: 10.1016/s0090-8258(02)00167-1. Gynecol Oncol. 2003. PMID: 12648597

10

Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.

Zhang L, Wang D, Jiang W, Edwards D, Qiu W, Barroilhet LM, Rho JH, Jin L, Seethappan V, Vitonis A, Wang J, Mok SC, Crum C, Cramer DW, Ye B. Zhang L, et al. Among authors: ye b. Reprod Biol Endocrinol. 2010 Jun 24;8:74. doi: 10.1186/1477-7827-8-74. Reprod Biol Endocrinol. 2010. PMID: 20576130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,441 results

Search Page

Filters